抗寄生虫薬の世界市場レポート 2025年

抗寄生虫薬市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR6.9％で336億4,000万米ドルに成長します。予測期間の成長は、新たな寄生虫の脅威、気候変動、媒介性疾患、世界ヘルスセキュリティの重視の高まり、ヘルスケアへのアクセスに起因しています。予測期間における主な動向としては、薬剤開発の進歩、標的療法、併用療法、官民パートナーシップ、遠隔医療、遠隔診断などが挙げられます。

媒介性疾患の発生率の増加は、抗寄生虫薬市場の成長を大きく牽引すると予想されます。蚊、ダニ、ハエなどの昆虫に刺されることで人に感染する媒介性疾患には、マラリア、デング熱、黄熱病などの疾患が含まれます。抗寄生虫薬は、これらの病気の原因となる寄生虫を駆除・制御する上で重要な役割を果たしており、病気の蔓延を抑え、公衆衛生への影響を軽減するのに役立っています。例えば、クロロキン、ドキシサイクリン、アトバコン・プログアニルなどの薬剤は、マラリアの治療に一般的に使用されています。米国疾病予防管理センター（CDC）によると、2024年6月には南北南北アメリカで970万人を超えるデング熱患者が報告され、2023年の460万人の2倍以上となりました。米国ではプエルトリコだけで1,498人のデング熱患者が報告され、そのうち745人は感染地域から帰国した旅行者でした。このような媒介性疾患の増加は、効果的な抗寄生虫治療に対する重大なニーズを明確にし、抗寄生虫薬市場の成長をさらに促進します。

寄生虫感染症の高い有病率は、抗寄生虫薬市場の成長を大きく牽引すると予想されます。原虫、ワムシ、リケッチアなどの生物によって引き起こされる寄生虫感染症は、深刻な健康脅威をもたらし、軽症から生命を脅かす重篤な疾患まで、さまざまな症状を引き起こす可能性があります。抗寄生虫薬は、これらの感染症の治療に不可欠であり、症状の緩和、合併症の予防、全体的な健康状態の改善に役立ちます。英国政府による2024年5月の報告によると、2022年にはイングランドとウェールズで31件のリケッチア感染症が報告されており、寄生虫感染症の根強さが浮き彫りになっています。世界的に寄生虫疾患の管理が課題となっている中、効果的な抗寄生虫治療薬に対する需要は今後も伸び続け、市場をさらに牽引していくと予想されます。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、コロナ、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界抗寄生虫薬PESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界の抗寄生虫薬市場：成長率分析
• 世界の抗寄生虫薬市場の実績：規模と成長, 2019-2024
• 世界の抗寄生虫薬市場の予測：規模と成長, 2024-2029, 2034F
• 世界抗寄生虫薬総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の抗寄生虫薬市場：製品タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 駆虫薬
• 抗原虫
• 外部寄生虫駆除剤
• 世界の抗寄生虫薬市場治療別、実績と予測, 2019-2024, 2024-2029F, 2034F
• アベルメクチン
• ベンジミダゾール
• ピリミジン
• 有機リン化合物
• イミダゾールチアゾール
• 世界の抗寄生虫薬市場：投与経路別、実績と予測, 2019-2024, 2024-2029F, 2034F
• オーラル
• 注射可能
• 話題
• 世界の抗寄生虫薬市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院
• ホームケア
• 専門クリニック
• その他のエンドユーザー
• 世界の抗寄生虫薬市場、駆虫薬の種類別のサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• ベンズイミダゾール
• イベルメクチン
• ピランテルパモエート
• プラジカンテル
• 世界の抗寄生虫薬市場抗原虫のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• メトロニダゾール
• チニダゾール
• ニタゾキサニド
• ペンタミジン
• 世界の抗寄生虫薬市場、外部寄生虫駆除剤の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• ペルメトリン
• マラチオン
• リンデン
• フィプロニル
• 世界の抗寄生虫薬市場、その他の製品のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 組み合わせ抗寄生虫薬
• 新規抗寄生虫薬

第7章 地域別・国別分析

• 世界の抗寄生虫薬市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の抗寄生虫薬市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 抗寄生虫薬市場：競合情勢
• 抗寄生虫薬市場：企業プロファイル
  • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
  • Cadila Pharmaceuticals Overview, Products and Services, Strategy and Financial Analysis
  • Merck & Co.Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Bayer AG Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Novartis AG
• Sanofi S.A.
• GlaxoSmithKline plc
• Takeda Pharmaceutical Company Limited
• Boehringer Ingelheim group
• Zoetis Inc.
• Eisai Co. Ltd.
• Covetrus Inc.
• IDEXX Laboratories Inc.
• Dr. Reddy's Laboratories
• Intas Pharmaceuticals Ltd
• Alkem Laboratories Ltd
• Ceva Sante Animale S.A.
• Elanco Animal Health Incorporated
• Phibro Animal Health Corporation

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 抗寄生虫薬市場2029：新たな機会を提供する国
• 抗寄生虫薬市場2029：新たな機会を提供するセグメント
• 抗寄生虫薬市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Antiparasitic drugs encompass a category of medications designed to combat infections triggered by a variety of parasites that have the potential to infest humans, animals, or plants. Parasites are living organisms that either reside on or within a host organism, drawing sustenance from it and often causing harm in the process. Antiparasitic drugs are formulated to specifically target these parasites, either by exterminating them or inhibiting their growth.

The primary product categories within antiparasitic drugs include anthelmintics, antiprotozoals, ectoparasiticides, and other related treatments. Anthelmintics, for instance, are a class of drugs tailored to address infections caused by parasitic worms. They operate by either eradicating the parasites or stunting their growth and reproductive capabilities. A diverse range of treatments falls under this category, including avermectins, benzimidazoles, pyrimidines, organophosphates, and imidazole thiazoles. These treatments can be administered through various means, such as orally, through injections, or topically, and are employed across a spectrum of end-users, including hospitals, homecare settings, specialty clinics, and others.

The antiparasitic drugs market research report is one of a series of new reports from The Business Research Company that provides antiparasitic drugs market statistics, including antiparasitic drugs industry global market size, regional shares, competitors with an antiparasitic drugs market share, detailed antiparasitic drugs market segments, market trends and opportunities and any further data you may need to thrive in the antiparasitic drugs industry. This antiparasitic drugs market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The antiparasitic drugs market size has grown strongly in recent years. It will grow from $24.06 billion in 2024 to $25.75 billion in 2025 at a compound annual growth rate (CAGR) of 7.0%. The growth in the historic period can be attributed to prevalence of parasitic infections, resistance to existing treatments, global health initiatives,.

The antiparasitic drugs market size is expected to see strong growth in the next few years. It will grow to $33.64 billion in 2029 at a compound annual growth rate (CAGR) of 6.9%. The growth in the forecast period can be attributed to emerging parasitic threats, climate change and vector-borne diseases, increased emphasis on global health security, access to healthcare. Major trends in the forecast period include advances in drug development, targeted therapies, combination therapies, public-private partnerships, telemedicine and remote diagnosis.

The increasing incidence of vector-borne diseases is expected to significantly drive the growth of the antiparasitic drugs market. Vector-borne diseases, which are transmitted to humans through the bites of insects such as mosquitoes, ticks, and flies, include conditions like malaria, dengue, and yellow fever. Antiparasitic drugs play a vital role in controlling and eliminating the parasites responsible for these diseases, helping to reduce their spread and impact on public health. For example, drugs like chloroquine, doxycycline, and atovaquone-proguanil are commonly used to treat malaria. According to the Centers for Disease Control and Prevention (CDC), in June 2024, over 9.7 million dengue cases were reported across the Americas, more than double the 4.6 million cases in 2023. In the U.S., Puerto Rico alone reported 1,498 dengue cases, with 745 cases among travelers returning from affected areas. This rise in vector-borne diseases underlines the critical need for effective antiparasitic treatments, further driving the growth of the antiparasitic drugs market.

The high prevalence of parasitic infections is expected to significantly drive the growth of the antiparasitic drug market. Parasitic infections, caused by organisms such as protozoa, worms, and rickettsia, pose a serious health threat and can lead to conditions ranging from mild illness to severe, life-threatening diseases. Antiparasitic drugs are crucial for treating these infections, helping to alleviate symptoms, prevent complications, and improve overall health outcomes. According to a May 2024 report by Gov. UK, in 2022, 31 rickettsial infection cases were reported in England and Wales, highlighting the persistence of parasitic infections. With ongoing challenges in managing parasitic diseases globally, the demand for effective antiparasitic treatments is expected to continue growing, further propelling the market.

Major companies operating in the antiparasitic drugs market are increasingly focusing on the development of innovative products, such as chewable veterinary medications, to improve ease of administration and enhance pet compliance. These chewable products are typically flavored, making them more appealing to pets and reducing the stress often associated with administering medications. For example, in April 2024, C.H. Boehringer Sohn AG & Co. KG, a Germany-based pharmaceutical company, launched NexGard Spectra. This soft, flavorful chew provides comprehensive parasite control for dogs, targeting fleas, ticks, heartworms, and various intestinal worms. NexGard Spectra is a highly effective treatment, killing fleas within four hours of administration and offering over 99% effectiveness against multiple parasites with a single monthly dose, further enhancing convenience and compliance for pet owners.

In June 2022, Orion Corporation, a pharmaceutical company headquartered in Finland, completed the acquisition of Inovet BV's animal health division for $141 million (€130 million). This strategic acquisition is anticipated to bolster Orion Corporation's presence in Western Europe and export markets, and it will also grant them access to a dedicated production facility specializing in the manufacturing of veterinary medicines. Inovet BV, based in Belgium, is a renowned veterinary pharmaceutical company known for its wide range of products, including antiparasitic treatments, antibiotics, and vaccines.

Major companies operating in the antiparasitic drugs market are Pfizer Inc., Johnson & Johnson, Cadila Pharmaceuticals, Merck & Co.Inc., Bayer AG, Novartis AG, Sanofi S.A., GlaxoSmithKline PLC, Takeda Pharmaceutical Company Limited, Boehringer Ingelheim group, Zoetis Inc., Eisai Co. Ltd., Covetrus Inc., IDEXX Laboratories Inc., Dr. Reddy's Laboratories, Intas Pharmaceuticals Ltd., Alkem Laboratories Ltd., Ceva Sante Animale S.A., Elanco Animal Health Incorporated, Phibro Animal Health Corporation, Norbrook Laboratories Ltd., Mankind Pharma, Neogen Corporation, Bimeda Inc., Indoco Remedies Ltd., ECO Animal Health, Lincoln Pharmaceuticals Ltd., Laboratorios Calier.

North America was the largest region in the antiparasitic drugs market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in antiparasitic drugs report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the antiparasitic drugs market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The antiparasitic drugs market consists of sales of antimalarial drugs, antiamoebic drugs, anti-trematode drugs and veterinary products. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Antiparasitic Drugs Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on antiparasitic drugs market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for antiparasitic drugs ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The antiparasitic drugs market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product Type: Anthelmintics; Antiprotozoals; Ectoparasiticide; Other Products
• 2) By Treatment: Avermectins; Bezimidazoles; Pyrimidines; Organophosphates; Imidazolesthiazoles
• 3) By Route of Administration: Oral; Injectable; Topical
• 4) By End User: Hospitals; Homecare; Specialty Clinics; Other End Users
• Subsegments:
• 1) By Anthelmintics: Benzimidazoles; Ivermectin; Pyrantel Pamoate; Praziquantel
• 2) By Antiprotozoals: Metronidazole; Tinidazole; Nitazoxanide; Pentamidine
• 3) By Ectoparasiticides: Permethrin; Malathion; Lindane; Fipronil
• 4) By Other Products: Combination Antiparasitic Drugs; Novel Antiparasitic Agents
• Companies Mentioned: Pfizer Inc.; Johnson & Johnson; Cadila Pharmaceuticals; Merck & Co.Inc.; Bayer AG
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Antiparasitic Drugs Market Characteristics

3. Antiparasitic Drugs Market Trends And Strategies

4. Antiparasitic Drugs Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Antiparasitic Drugs Growth Analysis And Strategic Analysis Framework

• 5.1. Global Antiparasitic Drugs PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Antiparasitic Drugs Market Growth Rate Analysis
• 5.4. Global Antiparasitic Drugs Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Antiparasitic Drugs Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Antiparasitic Drugs Total Addressable Market (TAM)

6. Antiparasitic Drugs Market Segmentation

• 6.1. Global Antiparasitic Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Anthelmintics
• Antiprotozoals
• Ectoparasiticide
• 6.2. Global Antiparasitic Drugs Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Avermectins
• Bezimidazoles
• Pyrimidines
• Organophosphates
• Imidazolesthiazoles
• 6.3. Global Antiparasitic Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oral
• Injectable
• Topical
• 6.4. Global Antiparasitic Drugs Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Homecare
• Specialty Clinics
• Other End Users
• 6.5. Global Antiparasitic Drugs Market, Sub-Segmentation Of Anthelmintics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Benzimidazoles
• Ivermectin
• Pyrantel Pamoate
• Praziquantel
• 6.6. Global Antiparasitic Drugs Market, Sub-Segmentation Of Antiprotozoals, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Metronidazole
• Tinidazole
• Nitazoxanide
• Pentamidine
• 6.7. Global Antiparasitic Drugs Market, Sub-Segmentation Of Ectoparasiticides, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Permethrin
• Malathion
• Lindane
• Fipronil
• 6.8. Global Antiparasitic Drugs Market, Sub-Segmentation Of Other Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Combination Antiparasitic Drugs
• Novel Antiparasitic Agents

7. Antiparasitic Drugs Market Regional And Country Analysis

• 7.1. Global Antiparasitic Drugs Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Antiparasitic Drugs Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Antiparasitic Drugs Market

• 8.1. Asia-Pacific Antiparasitic Drugs Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Antiparasitic Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Antiparasitic Drugs Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Antiparasitic Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Antiparasitic Drugs Market

• 9.1. China Antiparasitic Drugs Market Overview
• 9.2. China Antiparasitic Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Antiparasitic Drugs Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Antiparasitic Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Antiparasitic Drugs Market

• 10.1. India Antiparasitic Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Antiparasitic Drugs Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Antiparasitic Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Antiparasitic Drugs Market

• 11.1. Japan Antiparasitic Drugs Market Overview
• 11.2. Japan Antiparasitic Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Antiparasitic Drugs Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Antiparasitic Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Antiparasitic Drugs Market

• 12.1. Australia Antiparasitic Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Antiparasitic Drugs Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Antiparasitic Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Antiparasitic Drugs Market

• 13.1. Indonesia Antiparasitic Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Antiparasitic Drugs Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Antiparasitic Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Antiparasitic Drugs Market

• 14.1. South Korea Antiparasitic Drugs Market Overview
• 14.2. South Korea Antiparasitic Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Antiparasitic Drugs Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Antiparasitic Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Antiparasitic Drugs Market

• 15.1. Western Europe Antiparasitic Drugs Market Overview
• 15.2. Western Europe Antiparasitic Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Antiparasitic Drugs Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Antiparasitic Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Antiparasitic Drugs Market

• 16.1. UK Antiparasitic Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Antiparasitic Drugs Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Antiparasitic Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Antiparasitic Drugs Market

• 17.1. Germany Antiparasitic Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Antiparasitic Drugs Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Antiparasitic Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Antiparasitic Drugs Market

• 18.1. France Antiparasitic Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Antiparasitic Drugs Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Antiparasitic Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Antiparasitic Drugs Market

• 19.1. Italy Antiparasitic Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Antiparasitic Drugs Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Antiparasitic Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Antiparasitic Drugs Market

• 20.1. Spain Antiparasitic Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Antiparasitic Drugs Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Antiparasitic Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Antiparasitic Drugs Market

• 21.1. Eastern Europe Antiparasitic Drugs Market Overview
• 21.2. Eastern Europe Antiparasitic Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Antiparasitic Drugs Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Antiparasitic Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Antiparasitic Drugs Market

• 22.1. Russia Antiparasitic Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Antiparasitic Drugs Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Antiparasitic Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Antiparasitic Drugs Market

• 23.1. North America Antiparasitic Drugs Market Overview
• 23.2. North America Antiparasitic Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Antiparasitic Drugs Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Antiparasitic Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Antiparasitic Drugs Market

• 24.1. USA Antiparasitic Drugs Market Overview
• 24.2. USA Antiparasitic Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Antiparasitic Drugs Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Antiparasitic Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Antiparasitic Drugs Market

• 25.1. Canada Antiparasitic Drugs Market Overview
• 25.2. Canada Antiparasitic Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Antiparasitic Drugs Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Antiparasitic Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Antiparasitic Drugs Market

• 26.1. South America Antiparasitic Drugs Market Overview
• 26.2. South America Antiparasitic Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Antiparasitic Drugs Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Antiparasitic Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Antiparasitic Drugs Market

• 27.1. Brazil Antiparasitic Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Antiparasitic Drugs Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Antiparasitic Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Antiparasitic Drugs Market

• 28.1. Middle East Antiparasitic Drugs Market Overview
• 28.2. Middle East Antiparasitic Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Antiparasitic Drugs Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Antiparasitic Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Antiparasitic Drugs Market

• 29.1. Africa Antiparasitic Drugs Market Overview
• 29.2. Africa Antiparasitic Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Antiparasitic Drugs Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Antiparasitic Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Antiparasitic Drugs Market Competitive Landscape And Company Profiles

• 30.1. Antiparasitic Drugs Market Competitive Landscape
• 30.2. Antiparasitic Drugs Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Cadila Pharmaceuticals Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Merck & Co.Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Bayer AG Overview, Products and Services, Strategy and Financial Analysis

31. Antiparasitic Drugs Market Other Major And Innovative Companies

• 31.1. Novartis AG
• 31.2. Sanofi S.A.
• 31.3. GlaxoSmithKline plc
• 31.4. Takeda Pharmaceutical Company Limited
• 31.5. Boehringer Ingelheim group
• 31.6. Zoetis Inc.
• 31.7. Eisai Co. Ltd.
• 31.8. Covetrus Inc.
• 31.9. IDEXX Laboratories Inc.
• 31.10. Dr. Reddy's Laboratories
• 31.11. Intas Pharmaceuticals Ltd
• 31.12. Alkem Laboratories Ltd
• 31.13. Ceva Sante Animale S.A.
• 31.14. Elanco Animal Health Incorporated
• 31.15. Phibro Animal Health Corporation

32. Global Antiparasitic Drugs Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Antiparasitic Drugs Market

34. Recent Developments In The Antiparasitic Drugs Market

35. Antiparasitic Drugs Market High Potential Countries, Segments and Strategies

• 35.1 Antiparasitic Drugs Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Antiparasitic Drugs Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Antiparasitic Drugs Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer